Logo image of MSS

MAISON SOLUTIONS INC-A (MSS) Stock Fundamental Analysis

NASDAQ:MSS - Nasdaq - US5606671072 - Common Stock - Currency: USD

0.8999  +0.02 (+2.13%)

After market: 0.8999 0 (0%)

Fundamental Rating

2

Taking everything into account, MSS scores 2 out of 10 in our fundamental rating. MSS was compared to 41 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of MSS have multiple concerns. MSS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MSS has reported negative net income.
MSS had a positive operating cash flow in the past year.
MSS Yearly Net Income VS EBIT VS OCF VS FCFMSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of MSS (-1.60%) is worse than 68.29% of its industry peers.
MSS's Return On Equity of -11.05% is on the low side compared to the rest of the industry. MSS is outperformed by 68.29% of its industry peers.
The Return On Invested Capital of MSS (1.30%) is worse than 70.73% of its industry peers.
Industry RankSector Rank
ROA -1.6%
ROE -11.05%
ROIC 1.3%
ROA(3y)-0.86%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSS Yearly ROA, ROE, ROICMSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

MSS has a worse Operating Margin (0.88%) than 65.85% of its industry peers.
MSS has a Gross Margin (23.41%) which is in line with its industry peers.
MSS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.88%
PM (TTM) N/A
GM 23.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5YN/A
MSS Yearly Profit, Operating, Gross MarginsMSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

1

2. Health

2.1 Basic Checks

MSS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MSS has more shares outstanding
The debt/assets ratio for MSS is higher compared to a year ago.
MSS Yearly Shares OutstandingMSS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
MSS Yearly Total Debt VS Total AssetsMSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.35, we must say that MSS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.35, MSS is not doing good in the industry: 78.05% of the companies in the same industry are doing better.
MSS has a debt to FCF ratio of 3.73. This is a good value and a sign of high solvency as MSS would need 3.73 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.73, MSS is doing good in the industry, outperforming 70.73% of the companies in the same industry.
A Debt/Equity ratio of 1.01 is on the high side and indicates that MSS has dependencies on debt financing.
MSS's Debt to Equity ratio of 1.01 is on the low side compared to the rest of the industry. MSS is outperformed by 65.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 3.73
Altman-Z 1.35
ROIC/WACC0.13
WACC10.42%
MSS Yearly LT Debt VS Equity VS FCFMSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.57 indicates that MSS may have some problems paying its short term obligations.
With a Current ratio value of 0.57, MSS is not doing good in the industry: 92.68% of the companies in the same industry are doing better.
A Quick Ratio of 0.17 indicates that MSS may have some problems paying its short term obligations.
MSS has a Quick ratio of 0.17. This is amonst the worse of the industry: MSS underperforms 92.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.17
MSS Yearly Current Assets VS Current LiabilitesMSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

MSS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -352.34%.
MSS shows a strong growth in Revenue. In the last year, the Revenue has grown by 102.09%.
The Revenue has been growing by 12.10% on average over the past years. This is quite good.
EPS 1Y (TTM)-352.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%304.95%
Revenue 1Y (TTM)102.09%
Revenue growth 3Y12.1%
Revenue growth 5YN/A
Sales Q2Q%151.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MSS Yearly Revenue VS EstimatesMSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MSS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MSS Price Earnings VS Forward Price EarningsMSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MSS.
Based on the Price/Free Cash Flow ratio, MSS is valued cheaply inside the industry as 92.68% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.46
EV/EBITDA 11.36
MSS Per share dataMSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAISON SOLUTIONS INC-A

NASDAQ:MSS (6/3/2025, 8:00:00 PM)

After market: 0.8999 0 (0%)

0.8999

+0.02 (+2.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.44%
Inst Owner Change7.23%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.72M
AnalystsN/A
Price TargetN/A
Short Float %1.07%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF 5.46
P/OCF 4.7
P/B 1.48
P/tB N/A
EV/EBITDA 11.36
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.16
FCFY18.31%
OCF(TTM)0.19
OCFY21.28%
SpS5.68
BVpS0.61
TBVpS-0.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.6%
ROE -11.05%
ROCE 1.76%
ROIC 1.3%
ROICexc 1.31%
ROICexgc 2.16%
OM 0.88%
PM (TTM) N/A
GM 23.41%
FCFM 2.9%
ROA(3y)-0.86%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5YN/A
F-Score4
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 3.73
Debt/EBITDA 6.16
Cap/Depr 54.48%
Cap/Sales 0.47%
Interest Coverage 1.37
Cash Conversion 192.96%
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.17
Altman-Z 1.35
F-Score4
WACC10.42%
ROIC/WACC0.13
Cap/Depr(3y)249.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-352.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%304.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)102.09%
Revenue growth 3Y12.1%
Revenue growth 5YN/A
Sales Q2Q%151.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y460.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y172.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y211.6%
OCF growth 3YN/A
OCF growth 5YN/A